Improving the pharmacokinetic parameter measurement in dynamic contrast-enhanced MRI by use of the arterial input function: Theory and clinical application

Magnetic Resonance in Medicine

Volumn 59, Issue 6, 2008, Pages 1448-1456

  Yang, Xiangyu ^a   Liang, Jiachao ^a   Heverhagen, Johannes T ^a   Jia, Guang ^a   Schmalbrock, Petra ^a   Sammet, Steffen ^a   Koch, Regina ^a   Knopp, Michael V ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b 657 Means Hall ^*  (United States)

Author keywords

AIF; DCE MRI; Liver metastasis; Pharmacokinetic model

Indexed keywords

DIAGNOSIS; MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; TISSUE;

DCE-MRI; DYNAMIC CONTRAST ENHANCED MRI; DYNAMIC CONTRAST ENHANCED MRIS (DCE); LIVER METASTASIS; PHARMACOKINETIC ANALYSIS; PHARMACOKINETIC EQUATIONS; PHARMACOKINETIC MODEL; PHARMACOKINETIC PARAMETERS;

PHYSIOLOGICAL MODELS;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTERY; ARTICLE; CANCER PATIENT; CARDIOVASCULAR FUNCTION; CLASSIFIER; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DYNAMICS; HUMAN; LABORATORY DIAGNOSIS; LIVER METASTASIS; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHARMACOKINETICS; THEORETICAL MODEL; THEORETICAL STUDY; TISSUE SPECIFICITY; TISSUE TYPING;

EID: 44949249974     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21608     Document Type: Article

References (26)

1. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628.
2. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995;33:506-514.
3. Rosen MA, Schnall MD. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 2007;13(Pt 2):770s-776s.
4. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis - correlation with biopsy and histopathology. J Magn Reson Imaging 2006;24:108-113.
5. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003;17:509-520.
6. Lavini C, de Jonge MC, van de Sande MG, Tak PP, Nederveen AJ, Maas M. Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Reson Imaging 2007;25:604-612.
7. Knopp MV, Giesel FL, Marcos H, Tengg-Kobligk H, Choyke P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 2001;12:301-308.
8. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259.
9. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
10. Larsson HB, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131.
11. Larsson HB, Stubgaard M, Sondergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. J Magn Reson Imaging 1994;4:433-440.
12. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92:1599-1610.
13. Mross K, Drevs J, Muller M, Medinger M, Marme D, Hennig J, Morgan B, Lebwohl D, Masson E, Ho YY, Gunther C, Laurent D, Unger C. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur J Cancer 2005;41:1291-1299.
14. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564-568.
15. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
16. Shuter B, Tofts PS, Wang SC, Pope JM. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging 1996;14:243-253.
17. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994;32:66-76.
18. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
19. Bloembergen N. Proton relaxation times in paramagnetic solutions. J Chem Phys 1957;27:572-573.
20. Solomon I. Relaxation processes in a system of two spins. Phys Rev 1955;99:559-565.
21. Goldstein EJ, Burnett KR, Hansell JR, Casaia J, Dizon J, Farrar B, Gelblum D, Wolf GL. Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics. Physiol Chem Phys Med NMR 1984;16:97-104.
22. Gadian DG, Payne JA, Bryant DJ, Young IR, Carr DH, Bydder GM. Gadolinium-DTPA as a contrast agent in MR imaging - theoretical projections and practical observations. J Comput Assist Tomogr 1985;9:242-251.
23. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, Claussen CD, Schick F. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006;41:213-221.
24. Strich G, Hagan PL, Gerber KH, Slutsky RA. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA. Radiology 1985;154:723-726.
25. Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 1999;10:233-241.
26. Daniel BL, Yen YF, Glover GH, Ikeda DM, Birdwell RL, Sawyer-Glover AM, Black JW, Plevritis SK, Jeffrey SS, Herfkens RJ. Breast disease: dynamic spiral MR imaging. Radiology 1998;209:499-509.